Sinaptica Therapeutics
About
Sinaptica Therapeutics is a biotechnology startup dedicated to discovering and developing innovative treatments for neurodegenerative disorders. The company's research primarily targets synaptic dysfunction, a key pathological feature in conditions like Alzheimer's and Parkinson's diseases, aiming to restore neuronal communication and improve patient outcomes.
Frequently asked
What does Sinaptica Therapeutics do?
Sinaptica Therapeutics is a biotechnology startup dedicated to discovering and developing innovative treatments for neurodegenerative disorders. The company's research primarily targets synaptic dysfunction, a key pathological feature in conditions like Alzheimer's and Parkinson's diseases, aiming to restore neuronal communication and improve patient outcomes.
Where is Sinaptica Therapeutics headquartered?
Sinaptica Therapeutics is headquartered in Boston, United States.
When was Sinaptica Therapeutics founded?
Sinaptica Therapeutics was founded in 2021.
What industry does Sinaptica Therapeutics operate in?
Sinaptica Therapeutics operates in Biotech, MedTech, Neurodegenerative Diseases, Drug Discovery, Neuroscience, Synaptic Plasticity.
What is Sinaptica Therapeutics's current status?
Sinaptica Therapeutics's current operating status is: Inactive.
Comments
No comments yet. Be the first to share your take.